Drugs / CU-20101
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06585696 | Jun 2024 → Nov 2025 | — | Cutia Therapeutics (Wuxi) Co., Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CU-20101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06585696 ↗ |
| Modality | Protein / enzyme biologic | “Botulinum Toxin Type A for Injection (CU-20101)” NCT06585696 ↗ |